US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 13, 2022 (4 years ago)

Xylocaine - MPF (lidocaine HCl and epinephrine injection, USP), 1%, 300 mg/30 mL, single…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP deviations: Temperature abuse

What was recalled

Xylocaine - MPF (lidocaine HCl and epinephrine injection, USP), 1%, 300 mg/30 mL, single dose vial, 5-count box, Rx only, MFG: App Pharmaceuticals LLC, NDC 63323-0487-31

Recalling firm
Mckesson Medical-Surgical Inc. Corporate Office
NDC code
63323-0487-31
Origin
VA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1050-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Lidocaine recalls

See all